Highlights
- Applied in patients with thoracic trauma and acute respiratory failure
- Improved lung ventilation and oxygenation
- Enhanced secretion clearance and bronchial function
- Potential reduction in ICU stay and complications
Study Design
This study is a case series involving patients with:
- Severe chest trauma
- Acute respiratory failure
- Intensive care support
Vibroacoustic lung therapy (VALT) was integrated into standard care after stabilization.
Intervention characteristics:
- Application of emitters over affected lung areas
- Frequencies ranging from 20–300 Hz
- Short sessions (3–5 minutes), repeated multiple times per day
- Controlled intensity (20–30%)
Outcomes assessed:
- Oxygenation (PaO₂, P/F ratio)
- Lung compliance
- Radiological progression
- Respiratory clinical parameters
What Did They Find?
🫁 Improved lung function
- Increased lung compliance
- Improved ventilation/perfusion relationship
- Increased oxygenation (P/F ratio)
🌬️ Enhanced airway clearance
- Improved secretion mobilization
- Better bronchial drainage
- Effects observed during bronchoscopy
📉 Clinical impact
- Reduced mechanical ventilation duration
- Shorter ICU stays
- Favorable outcomes even in severe cases
Why It Matters
👉 Vibroacoustic therapy directly influences respiratory physiology.
It provides:
⚡ Active physiological effects
- Mechanical vibration of lung tissue
- Improved perfusion
- Enhanced alveolar ventilation
- Facilitation of mucus clearance
Mechanism Insight
- Low-frequency sound waves (20–300 Hz)
- Tissue resonance in chest and lungs
- Oscillatory mechanical stimulation
Lung compliance before and after vibroacoustic pulmonary therapy (VALT) in patients with thoracic trauma and acute respiratory failure. All cases demonstrated increased compliance following intervention, suggesting improved pulmonary mechanics.
Reference: Konkayev A, Bekniyazova A, Khamidullina Z, Konkayeva M. Case series report: use of vibroacoustic pulmonary therapy in patients with thoracic trauma complicated by acute respiratory failure. Front Med (Lausanne). 2024;11:1399397. Published 2024 Sep 4. doi:10.3389/fmed.2024.1399397
Read the full paper: Click here